Practical Guidance to Implementing Quality Management Systems in Public Health Laboratories Performing Next-Generation Sequencing: Personnel, Equipment, and Process Management (Phase 1).


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
08 2019
Historique:
pubmed: 31 5 2019
medline: 23 7 2020
entrez: 31 5 2019
Statut: epublish

Résumé

Quality standards as part of an effective quality management system (QMS) are the cornerstone for generating high-quality test results. Next-generation sequencing (NGS) has the potential to improve both clinical diagnostics and public health surveillance efforts in multiple areas, including infectious diseases. However, the laboratories adopting NGS methods face significant challenges due to the complex and modular process design. This document summarizes the first phase of quality system guidance developed by the Centers for Disease Control and Prevention (CDC) NGS Quality Workgroup. The quality system essentials of personnel, equipment, and process management (quality control and validation) were prioritized based on a risk assessment using information gathered from participating CDC laboratories. Here, we present a prioritized QMS framework, including procedures and documentation tools, to assist laboratory implementation and maintenance of quality practices for NGS workflows.

Identifiants

pubmed: 31142608
pii: JCM.00261-19
doi: 10.1128/JCM.00261-19
pmc: PMC6663893
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Dhwani Batra (D)
Ruffin Booth (R)
Erin Breaker (E)
Maria Elena Casas (ME)
Blake Cherney (B)
How Yi Chang (HY)
Jonathan Daniels (J)
Jennifer Driggers (J)
D. Matthew Eby (DM)
Amy Gargis (A)
Jay Gee (J)
Nicole A. Gregoricus (NA)
Jessica L. Halpin (JL)
Raveena Khemani (R)
Meredith Korth (M)
Yasvanth Kulasekarapandian (Y)
Genevieve Langley (G)
Ana C. Lauer (AC)
Ira M. Lubin (IM)
Jeanine A. McLean (JA)
Alexandra Mercante (A)
Allison Myrick (A)
Sheila Okoth (S)
K. Allison Perry (KA)
Edward Ramos (E)
Matthew Schmerer (M)
Mili Sheth (M)
Maryann Turnsek (M)
Nicholas Vlachos (N)
Grant M. Williams (GM)

Références

J Clin Microbiol. 2016 Dec;54(12):2857-2865
pubmed: 27510831
J Clin Microbiol. 2017 Aug;55(8):2502-2520
pubmed: 28592550

Auteurs

Rebecca J Hutchins (RJ)

Office of the Deputy Director of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Kristy L Phan (KL)

Office of the Deputy Director of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Adeeba Saboor (A)

Division of laboratory Systems, Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Joseph D Miller (JD)

Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Atis Muehlenbachs (A)

Office of the Deputy Director of Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA vkd6@cdc.gov.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH